secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001437749-25-017680
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics approves 1-for-15 reverse stock split effective May 27, 2025 to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split ratio set at 1-for-15; effective 12:01 a.m. PT on May 27, 2025.
- Post-split shares ~2.35M vs pre-split ~35.3M; par value unchanged at $0.001.
- Stock will trade on Nasdaq (symbol EKSO) on split-adjusted basis; new CUSIP 282644400.
- Fractional shares rounded up to next whole share; no proportional cut in authorized shares.
- Purpose: raise per-share price to meet $1 minimum bid for 10 consecutive trading days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925017680/0001437749-25-017680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925017680/ekso20250516c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-017680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer